MedTrace Logo

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA

NCT06049342 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-01-19

No results posted yet for this study

Summary

This clinical study is to investigate the safety and efficacy of NCR100 injection in subjects with knee osteoarthritis (KOA). It is a dose-escalating, open label study in adult KOA subjects.

Conditions

Interventions

BIOLOGICAL

NCR100 injection

Subjects will receive a one-dose intra-articular NCR100 injection.

Sponsors & Collaborators

  • Shanghai 6th People's Hospital

    collaborator OTHER

  • Beijing Luhe Hospital

    collaborator OTHER

  • Nuwacell Biotechnologies Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Changqing Zhang · Shanghai 6th People's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-25
Primary Completion
2024-06-30
Completion
2025-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049342 on ClinicalTrials.gov